The NORSCREEN trial will assess whether self-examination with ECG247, detection of previously unknown atrial fibrillation and initiation of preventive treatment can avoid stroke. The study will include 20,000 participants ≥65 years with up to 5 years follow-up. Oslo University Hospital and professor Sigrun Halvorsen are responsible for the study

Read more at NORSCREEN.org